Seaport Therapeutics, Inc. (SPTX) Misses Q3 EPS by 49c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq rallies as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts SPTX Hot Sheet
Join SI Premium – FREE
Seaport Therapeutics, Inc. (NASDAQ: SPTX) reported Q3 EPS of ($0.49), $0.49 worse than the analyst estimate of $0.00.
For earnings history and earnings-related data on Seaport Therapeutics, Inc. (SPTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Downgrades PayPal (PYPL) to Hold
- SK Hynix’s US expansion plans hit snag over China license delays - report
- Canaccord Downgrades Driven Brands (DRVN) to Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
